Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 2
2009 2
2011 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
A phase II study of biweekly mitomycin C and irinotecan combination therapy in patients with fluoropyrimidine-resistant advanced gastric cancer: a report from the Gastrointestinal Oncology Group of the Japan Clinical Oncology Group (JCOG0109-DI Trial).
Hamaguchi T, Shirao K, Ohtsu A, Hyodo I, Arai Y, Takiuchi H, Fujii H, Yoshida M, Saito H, Denda T, Koizumi W, Iwase H, Boku N; Gastrointestinal Oncology Study Group of Japan Clinical Oncology Group. Hamaguchi T, et al. Gastric Cancer. 2011 Aug;14(3):226-33. doi: 10.1007/s10120-011-0030-8. Epub 2011 Apr 19. Gastric Cancer. 2011. PMID: 21503598 Clinical Trial.
A phase II study of sequential methotrexate and 5-fluorouracil chemotherapy in previously treated gastric cancer: a report from the Gastrointestinal Oncology Group of the Japan Clinical Oncology Group, JCOG 9207 trial.
Hamaguchi T, Shirao K, Yamamichi N, Hyodo I, Koizumi W, Seki S, Imamura T, Honma H, Ohtsu A, Boku N, Mukai T, Yamamoto S, Fukuda H, Yoshida S; Gastrointestinal Oncology Study Group of Japan Clinical Oncology Group. Hamaguchi T, et al. Jpn J Clin Oncol. 2008 Jun;38(6):432-7. doi: 10.1093/jjco/hyn043. Epub 2008 May 30. Jpn J Clin Oncol. 2008. PMID: 18515821 Clinical Trial.
A phase II trial of combined treatment of endoscopic mucosal resection and chemoradiotherapy for clinical stage I esophageal carcinoma: Japan Clinical Oncology Group Study JCOG0508.
Kurokawa Y, Muto M, Minashi K, Boku N, Fukuda H; Gastrointestinal Oncology Study Group of Japan Clinical Oncology Group (JCOG). Kurokawa Y, et al. Jpn J Clin Oncol. 2009 Oct;39(10):686-9. doi: 10.1093/jjco/hyp078. Epub 2009 Aug 24. Jpn J Clin Oncol. 2009. PMID: 19703839 Free PMC article. Clinical Trial.
Significance of biological markers for predicting prognosis and selecting chemotherapy regimens of advanced gastric cancer patients between continuous infusion of 5-FU and a combination of 5-FU and cisplatin.
Boku N, Ohtsu A, Yoshida S, Shirao K, Shimada Y, Hyodo I, Saito H, Miyata Y; Gastrointestinal Oncology Study Group of Japan Clinical Oncology Group (GIOSG/JCOG). Boku N, et al. Jpn J Clin Oncol. 2007 Apr;37(4):275-81. doi: 10.1093/jjco/hym015. Epub 2007 May 23. Jpn J Clin Oncol. 2007. PMID: 17522103
Chemotherapy for metastatic disease: review from JCOG trials.
Boku N; Gastrointestinal Oncology Study Group of Japan Clinical Oncology Group. Boku N, et al. Int J Clin Oncol. 2008 Jun;13(3):196-200. doi: 10.1007/s10147-008-0784-0. Epub 2008 Jun 14. Int J Clin Oncol. 2008. PMID: 18553227 Review.